metformin has been researched along with maytansine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CM; Chang, KJ; Chang, TW; Chao, WT; Chung, YC; Wei, WC | 1 |
1 other study(ies) available for metformin and maytansine
Article | Year |
---|---|
Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Agents, Immunological; Breast Neoplasms; Caveolin 1; Drug Resistance, Neoplasm; Drug Synergism; Endocytosis; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Immunoconjugates; Maytansine; Metformin; Receptor, ErbB-2; Signal Transduction; Trastuzumab; Tumor Cells, Cultured | 2018 |